Ed Thornborrow, MD, PhD

Title(s)Professor, Laboratory Medicine
SchoolSchool of Medicine
Address185 Berry Street Bldg B
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Mount SinaiM.D., Ph.D.2003School of Medicine
    UCSFResidency2008Laboratory Medicine and Anatomic Pathology
    UCSFFellowship, Hematopathology2009Laboratory Medicine

    Collapse Overview 
    Collapse Overview
    As Medical Director of the UCSF Clinical Laboratories, I am responsible for the overall quality management of our pre-analytical, analytical, and post-analytical processes. This includes oversight of all clinical laboratory sections, as well as inpatient and outpatient point of care testing and phlebotomy services.

    In addition, as a board certified hematopathologist, I attend on the UCSF hematopathology and flow cytometry services, where I specialize in the diagnosis of leukemias and lymphomas.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Electrophoretic mobility shift analysis of the DNA binding of tumor suppressor gene products. Methods Mol Biol. 2003; 223:87-100. Thornborrow EC, Maurer M, Manfredi JJ. PMID: 12777722.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene. 2002 Feb 07; 21(7):990-9. Thornborrow EC, Patel S, Mastropietro AE, Schwartzfarb EM, Manfredi JJ. PMID: 11850816.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    3. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. J Biol Chem. 2001 May 11; 276(19):15598-608. Thornborrow EC, Manfredi JJ. PMID: 11278953.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    4. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element. J Biol Chem. 1999 Nov 19; 274(47):33747-56. Thornborrow EC, Manfredi JJ. PMID: 10559267.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells